Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Novartis Pharmaceuticals Australia Pty Limited

02 7Novartis Pharmaceuticals Corporation

03 1Novartis South Africa (Pty) Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

brolucizumab-dbll

Brand Name : BEOVU

Dosage Form : INJECTABLE; INTRAVITREAL

Dosage Strength : 6MG/0.05ML

Packaging :

Approval Date :

Application Number : 761125

Regulatory Info :

Registration Country : USA

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Brolucizumab

Brand Name : Beovu

Dosage Form : Injectable Solution

Dosage Strength : 120mg/ml

Packaging :

Approval Date : 13/02/2020

Application Number : 20190208000040

Regulatory Info : Approved

Registration Country : Sweden

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Brolucizumab

Brand Name : Beovu

Dosage Form : Solution For Injection

Dosage Strength : 120mg/ml

Packaging :

Approval Date : 13/02/2020

Application Number : 20190208000057

Regulatory Info : Approved

Registration Country : Sweden

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Brolucizumab

Brand Name : Beovu

Dosage Form : Solution For Injection

Dosage Strength : 120mg/ml

Packaging :

Approval Date : 16/01/2020

Application Number : 67244

Regulatory Info : Allowed

Registration Country : Switzerland

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Brolucizumab

Brand Name : Beovu

Dosage Form : Solution For Injection

Dosage Strength : 120mg/ml

Packaging :

Approval Date : 16/01/2020

Application Number : 67245

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

BROLUCIZUMAB

Brand Name : BEOVU

Dosage Form : SOLUTION

Dosage Strength : 6MG/0.05ML

Packaging :

Approval Date :

Application Number : 2496976

Regulatory Info : Prescription

Registration Country : Canada

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Brolucizumab

Brand Name : Beovu

Dosage Form : Injectable Solution In Pre-Filled Syringe

Dosage Strength : 120MG

Packaging :

Approval Date : 2020-02-28

Application Number : 1191417

Regulatory Info : Authorized

Registration Country : Spain

blank

08

Novartis South Africa (Pty) Ltd

Country
The MedTech Conference
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
The MedTech Conference
Not Confirmed

Brolucizumab

Brand Name : Vsiqq

Dosage Form : INJ

Dosage Strength : 120mg/ml

Packaging : 0.23X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

09

Novartis Pharmaceuticals Australia ...

Country
The MedTech Conference
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
The MedTech Conference
Not Confirmed

Brolucizumab

Brand Name : Beovu

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank